Bexarotene
- Product NDC
- 0832-0285
- 11-digit product format
- 008320285
- Labeler code
- 0832
- Product ID
- 0832-0285_0392c67b-a83c-4e6c-95d6-09604953652d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bexarotene
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Upsher-Smith Laboratories, Inc.
- Application
- ANDA209886
- Marketing category
- ANDA
- Marketing start
- 2018-07-25
- Substance
- BEXAROTENE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bexarotene
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEXAROTENE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A61RXM4375 |
| Rxcui | 308725 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0832-0285-00 | Bexarotene | 100 in 1 BOTTLE | CAPSULE | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0832-0285 | BEXAROTENE CAPSULE [UPSHER-SMITH LABORATORIES, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20230415_7437a43f-172a-4f4e-8132-fe23b00224f9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0832-0285-00 | 00832028500 | 100 CAPSULE in 1 BOTTLE (0832-0285-00) | 100 capsule | 2018-07-25 | 0000-00-00 | No | No | Current |